Emyria expands clinical sites for EMD-RX5 Phase 3 trial
Released
Latest announcements
Ask a question
Your question will be sent privately to Emyria. The company may choose to make this question public.
Investor Q&As
Start the conversation
Ask Emyria a question about this announcement.